Sudarshan Pharma Industries (BOM:543828) Marketable Securities: ₹ Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:543828 Sudarshan Pharma Industries Ltd BOM:543828
74 GF Score
Price ₹39.67
GF Value ₹39.04
Valuation Fairly Valued
! 13 Warning Signs
View Full Analysis

What is Sudarshan Pharma Industries Marketable Securities?

Sudarshan Pharma Industries BOM:543828 -0.58% 74 Marketable Securities is ₹ Mil as of Jun. 2026. GuruFocus rates BOM:543828 with a GF Score™ of 74/100 and a GF Value™ of ₹39.04 (Fairly Valued). The stock has 13 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Sudarshan Pharma Industries's Marketable Securities for the quarter that ended in Jun. 2026 was ₹ Mil.

Sudarshan Pharma Industries's annual Marketable Securities increased from Mar. 2024 (₹58 Mil) to Mar. 2025 (₹68 Mil) and increased from Mar. 2025 (₹68 Mil) to Mar. 2026 (₹97 Mil).

Sudarshan Pharma Industries  (BOM:543828) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Sudarshan Pharma Industries Marketable Securities Related Terms

Sudarshan Pharma Industries Marketable Securities Historical Data

* Premium members only.

The historical data trend for Sudarshan Pharma Industries's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sudarshan Pharma Industries Marketable Securities Chart

Sudarshan Pharma Industries Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Marketable Securities
Get a 7-Day Free Trial 0.00 0.00 58.22 68.26 97.22

Sudarshan Pharma Industries Quarterly Data
Jun22 Jun25 Sep25 Dec25 Mar26 Jun26
Marketable Securities Get a 7-Day Free Trial - 17.29 - 97.22 -
BOM:543828
74GF Score
Sudarshan Pharma Industries Ltd BOM:543828
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sudarshan Pharma Industries Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of ₹ Mil mean?
Sudarshan Pharma Industries (BOM:543828) has a Marketable Securities of ₹ Mil as of Jun. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Sudarshan Pharma Industries and its competitors.
Is Sudarshan Pharma Industries' Marketable Securities too high?
Sudarshan Pharma Industries' current Marketable Securities is ₹ Mil. Overall, Sudarshan Pharma Industries has a GF Score™ of 74/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Sudarshan Pharma Industries' Marketable Securities compare to DOW?
Sudarshan Pharma Industries' Marketable Securities of ₹ Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Chemicals company?
A good Marketable Securities depends on the Chemicals industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Sudarshan Pharma Industries and its competitors. Sudarshan Pharma Industries's current Marketable Securities is ₹ Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sudarshan Pharma Industries stock overvalued right now?
Based on GuruFocus' analysis, Sudarshan Pharma Industries (BOM:543828) is currently considered Fairly Valued. The stock's GF Value™ is ₹39.04, compared to a current price of ₹39.67 — trading 1.6% above its estimated fair value. The current Marketable Securities is ₹ Mil. Sudarshan Pharma Industries' overall GF Score™ is 74/100 with 13 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Sudarshan Pharma Industries (BOM:543828), the current Marketable Securities is ₹ Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sudarshan Pharma Industries (BOM:543828) Overvalued in 2026?

Based on GuruFocus' analysis, Sudarshan Pharma Industries stock appears to be overvalued. The current stock price of ₹39.67 is trading 1.6% above its estimated GF Value™ of ₹39.04. GuruFocus considers Sudarshan Pharma Industries to be Fairly Valued.

Key valuation signals for BOM:543828:

  • Marketable Securities: ₹ Mil
  • GF Value™: ₹39.04 vs. price of ₹39.67 (1.6% above fair value)
  • GF Score™: 74/100 with 13 warning signs

No single metric tells the full story. See the BOM:543828 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sudarshan Pharma Industries Business Description

Address S V Road, 301, 3rd Floor, Aura Biplex, Above Kalyan Jewellers, Borivali (West), Mumbai, MH, IND, 400092
Sudarshan Pharma Industries Ltd operates in the pharmaceutical and chemical industries, focusing on specialty chemicals and intermediates used in pharmaceuticals, paints, food products, and adhesives. The Company has a presence domestically and internationally, participating regularly in trade fairs and exhibitions. The Company exports mainly to South East Asia, the Middle East, and North Africa. The Company also supplies generic pharmaceutical formulation as 'Make to order' for bulk supply to hospitals and related healthcare organisations. The company has one reportable segment of Specialty Chemicals.
74GF Score

Get the complete analysis for BOM:543828

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹39.67
Price
₹39.04
GF Value